These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15494295)

  • 1. Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.
    Foss FM
    Best Pract Res Clin Haematol; 2004 Dec; 17(4):573-84. PubMed ID: 15494295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.
    Beran M
    Int J Hematol; 2000 Aug; 72(2):139-50. PubMed ID: 11039661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic agents for the treatment of myelodysplastic syndromes.
    Cheson BD; Zwiebel JA; Dancey J; Murgo A
    Semin Oncol; 2000 Oct; 27(5):560-77. PubMed ID: 11049023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of angiogenesis in patients with myelodysplastic syndrome.
    Estey EH
    Best Pract Res Clin Haematol; 2004 Dec; 17(4):623-39. PubMed ID: 15494299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New agents in myelodysplastic syndromes.
    Jabbour EJ; Giles FJ
    Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of angiogenesis in the biology and therapy of myelodysplastic syndromes.
    Aguayo A
    Curr Hematol Rep; 2004 May; 3(3):184-91. PubMed ID: 15087066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating myelodysplastic syndromes.
    Ryan C; McCann S
    IDrugs; 2005 Apr; 8(4):320-6. PubMed ID: 15800807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating novel agents in the treatment of myelodysplastic syndromes.
    Anargyrou K; Vassilakopoulos TP; Angelopoulou MK; Terpos E
    Leuk Res; 2010 Jan; 34(1):6-17. PubMed ID: 19656566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the therapy for myelodysplastic syndrome.
    Kasner MT; Luger SM
    Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies for myelodysplastic syndromes.
    Faderl S; Kantarjian HM
    Cancer; 2004 Jul; 101(2):226-41. PubMed ID: 15241818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
    Suwanawiboon B; Sumida KN
    Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with higher risk myelodysplastic syndromes.
    Fukumoto JS; Greenberg PL
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):179-92. PubMed ID: 15979321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in myelodysplastic syndromes.
    Shadduck RK; Latsko JM; Rossetti JM; Haq B; Abdulhaq H
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):137-43. PubMed ID: 17379099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase inhibitors in myelodysplastic syndrome.
    Silverman LR
    Best Pract Res Clin Haematol; 2004 Dec; 17(4):585-94. PubMed ID: 15494296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
    Kantarjian H; Beran M; Cortes J; O'Brien S; Giles F; Pierce S; Shan J; Plunkett W; Keating M; Estey E
    Cancer; 2006 Mar; 106(5):1099-109. PubMed ID: 16435387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational research in myelodysplastic syndromes.
    Raza A; Qawi H; Mehdi M; Mumtaz M; Galili N
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E2. PubMed ID: 16027100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel agents for the management of myelodysplastic syndromes.
    Meletis J; Viniou N; Terpos E
    Med Sci Monit; 2006 Sep; 12(9):RA194-206. PubMed ID: 16940944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of signaling in myelodysplastic syndrome.
    Gore SD
    Best Pract Res Clin Haematol; 2004 Dec; 17(4):613-22. PubMed ID: 15494298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Blood Rev; 2008 Mar; 22(2):75-91. PubMed ID: 18068281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to the treatment of myelodysplasia.
    List AF
    Oncologist; 2002; 7 Suppl 1():39-49. PubMed ID: 11961208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.